InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small...
Read moreContango ORE (NYSEAMERICAN:CTGO) and Dolly Varden Silver (TSXV:DV) have agreed to merge in an all-stock deal that would create a...
Read moreThe Bank of Canada Governing Council met on Wednesday (December 10) for the final rate-setting meeting of 2025 and decided...
Read moreWe also break down next week’s catalysts to watch to help you prepare for the week ahead. In this article:...
Read moreRio Silver Inc. (the ‘Company’ or ‘Rio Silver’) (TSX.V: RYO,OTC:RYOOF) (OTC: RYOOF) announces that, following regulatory approval, the closing of...
Read more(TheNewswire) Vancouver, Canada, December 12, 2025 TheNewswire – Spartan Metals Corp. (‘ Spartan ‘ or the ‘ Company ‘) (TSX-V:...
Read more2025 is drawing to a close, and silver seems determined to end the year with a bang. The white metal’s...
Read moreBold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the closing of a non-brokered private placement offering...
Read moreKEY HIGHLIGHTS: MIE has successfully completed testing, confirming suitability of Santa Maria Eterna silica sand for high quality, antimony-free glass...
Read moreThis article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Disclosure: This does not represent...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved